Literature DB >> 9741500

Mast cell infiltration in acute coronary syndromes: implications for plaque rupture.

M Kaartinen1, A C van der Wal, C M van der Loos, J J Piek, K T Koch, A E Becker, P T Kovanen.   

Abstract

OBJECTIVES: To define the role of mast cells in plaque destabilization.
BACKGROUND: Inflammation is an essential feature of human coronary plaques. Macrophages and T lymphocytes are considered to contribute to destabilization of the plaques. The role of mast cells in this setting is less well studied. We therefore counted the mast cells in coronary atherectomy specimens from patients with chronic stable angina, unstable angina and severe unstable angina.
METHODS: Patients studied had chronic stable angina (group 1, n=11), "stabilized" unstable angina (group 2; Braunwald's class I and II, n=11) and "refractory" unstable angina (group 3; Braunwald's class III, n=7). Samples of culprit lesions (n=29) were obtained by directional atherectomy, snap-frozen and analyzed immunohistochemically. The numbers of mast cells and T lymphocytes per square millimeter squared were counted and the areas containing macrophages and smooth muscle cells were measured by computed planimetry.
RESULTS: We found that the numbers of mast cells and T lymphocytes increased from group 1 through groups 2 to 3. Specimens from group 3 also contained the largest numbers of tumor necrosis factor alpha (TNF-alpha)-positive mast cells and of matrix metalloproteinase (MMP)-9 (92 kD gelatinase)-positive macrophages.
CONCLUSIONS: Unstable coronary syndromes are associated with increased numbers of mast cells in culprit lesions. Activated mast cells secrete neutral proteases capable of degrading the extracellular matrix and TNF-alpha, capable of stimulating macrophages to synthesize MMP-9. Our observations suggest that mast cells, in addition to macrophages, contribute to matrix degradation and, hence, to progression of coronary syndromes.

Entities:  

Mesh:

Year:  1998        PMID: 9741500     DOI: 10.1016/s0735-1097(98)00283-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  13 in total

1.  Coronary artery disease, inflammation and the ghost of John Hunter.

Authors:  Ernest L Fallen
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

2.  Participation of mast cells in angiogenesis in the border zone of myocardial infarction in rats.

Authors:  Takayoshi Yamaki; Masumi Iwai-Takano; Hiroyuki Yaoita; Kazuei Ogawa; Hiroko Tajima; Yasuchika Takeishi; Yukio Maruyama
Journal:  J Med Ultrason (2001)       Date:  2009-08-15       Impact factor: 1.314

3.  Immunological Aspects of Age-Related Macular Degeneration.

Authors:  Michael J Allingham; Anna Loksztejn; Scott W Cousins; Priyatham S Mettu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Inverse correlation between soluble CD40 ligand and soluble CD40 is absent in patients with unstable angina.

Authors:  Michitaka Tsuzuki; Itsuro Morishima; Tomohiro Yoshida; Yuzo Hayashi; Manabu Miura; Toshihisa Hirai; Toru Asai; Yasushi Numaguchi; Takahito Sone; Hideo Matsui; Kenji Okumura; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2005-11       Impact factor: 2.037

5.  Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.

Authors:  Nobuo Sakamoto; Yasuto Hoshino; Tomofumi Misaka; Hiroyuki Mizukami; Satoshi Suzuki; Koichi Sugimoto; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2013-03-27       Impact factor: 2.037

Review 6.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

7.  Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.

Authors:  Min Cheng; Satwat Hashmi; Xiaobo Mao; Qiu Tang Zeng
Journal:  Can J Cardiol       Date:  2008-05       Impact factor: 5.223

Review 8.  Inflammation and immune response in atherosclerosis.

Authors:  G K Hansson
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.967

9.  Advanced glycation end products as a source of artifacts in immunoenzymatic methods.

Authors:  Aleksandra Kuzan; A Chwiłkowska; K Maksymowicz; A Bronowicka-Szydełko; K Stach; C Pezowicz; A Gamian
Journal:  Glycoconj J       Date:  2018-01-05       Impact factor: 2.916

Review 10.  Unstable carotid artery plaque: new insights and controversies in diagnostics and treatment.

Authors:  Karolina Skagen; Mona Skjelland; Mahtab Zamani; David Russell
Journal:  Croat Med J       Date:  2016-08-31       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.